Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement

Anthill Cloud: Transforming Pharma Marketing with AI, Modular Content, and Omnichannel Engagement

COPENHAGEN, Denmark, Nov. 3, 2025 /PRNewswire/ -- Anthill , a leading content excellence and technology partner to the life sciences industry, has announced the launch of Anthill Cloud™ — an innovative platform that combines AI, modular content, and...

Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS

Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS

Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in...

LEPAS Shines at the 2025 Chery International User Summit, Where "Technology Meets Elegance" to Define a New Way of Life

LEPAS Shines at the 2025 Chery International User Summit, Where "Technology Meets Elegance" to Define a New Way of Life

WUHU, China, Nov. 3, 2025 /PRNewswire/ -- From October 17 to 21, the 2025 Chery International User Summit held in Wuhu, Anhui. As Chery Group's all-new new energy brand, LEPAS presented its brand character through a series of activities. In the...

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'

YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been...

Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer

Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer

HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer...

CUSTA Renews Platform with 4,000-Item Catalogue and Unlimited Customisation, First of Its Kind in Singapore at Scale

CUSTA Renews Platform with 4,000-Item Catalogue and Unlimited Customisation, First of Its Kind in Singapore at Scale

2nd anniversary marks service upgrade introducing instant pricing & design flexibility; aligned with Singapore's $113.2B digital economy growth and strong SME tech adoption. SINGAPORE, Nov. 3, 2025 /PRNewswire/ -- CUSTA , a leading regional...

Star Plus Legend Holdings Limited Steps In as Investor, Perfecting Galaxy's Capital Framework for Its Korean IPO Drive

Star Plus Legend Holdings Limited Steps In as Investor, Perfecting Galaxy's Capital Framework for Its Korean IPO Drive

HONG KONG, Nov. 3, 2025 /PRNewswire/ -- As a pioneer in the AI entertainment technology space, Galaxy Corporation delivered growth against the market tide in the first half of 2025: its sales hit 126 billion Korean won and net profit reached 13...

NAVER D2SF-backed Nota AI Lists on KOSDAQ, Embarking on Global Expansion in AI Model Compression and Optimization

NAVER D2SF-backed Nota AI Lists on KOSDAQ, Embarking on Global Expansion in AI Model Compression and Optimization

Successfully listed on KOSDAQ with unique competitiveness for AI lightweighting and optimization technology Driving rapid annual revenue growth through collaborations with global leaders including NVIDIA, Samsung Electronics, and Qualcomm Focusing...

Oxford Instruments introduces the witec360 Raman Microscope with Hexalight Spectrometer to advance research in Singapore and across Southeast Asia

Oxford Instruments introduces the witec360 Raman Microscope with Hexalight Spectrometer to advance research in Singapore and across Southeast Asia

LONDON, Nov. 3, 2025 /PRNewswire/ -- Oxford Instruments today announced the launch of its witec360 Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The new system delivers...

Caregility and MOD3RN Care Partner to Modernise Healthcare Delivery in Australia

Caregility and MOD3RN Care Partner to Modernise Healthcare Delivery in Australia

WALL, N.J. and BARANGAROO, Australia, Nov. 3, 2025 /PRNewswire/ -- Caregility Corporation, a global enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through innovative virtual care and AI-powered...

  • 1
  • ...
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • ...
  • 205
  • menu
    menu